Steven J Knox Selected Research

Fibrosis (Cirrhosis)

11/2022	Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
11/2016	A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.
10/2016	Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection.
7/2016	Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.
1/2016	A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.
1/2016	Efficacy of sofosbuvir plus ribavirin in treatment-naive patients with genotype-1 and -3 HCV infection: results from a Russian Phase IIIb study.
6/2015	Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven J Knox Research Topics

Disease

11	Infections 04/2024 - 05/2015
7	Fibrosis (Cirrhosis) 11/2022 - 06/2015
4	Chronic Hepatitis C 11/2016 - 01/2016
4	Hepatitis C 10/2016 - 06/2015
3	Chronic Hepatitis B 04/2024 - 11/2022
2	Headache (Headaches) 07/2016 - 06/2015
2	Infarction (Infarctions) 01/2015 - 01/2012
1	Viremia 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Nasopharyngitis 06/2015
1	Edema (Dropsy) 01/2015
1	Aneurysm (Aneurysms) 01/2012
1	Stroke (Strokes) 01/2012

Drug/Important Bio-Agent (IBA)

8	Ribavirin (Virazole)FDA LinkGeneric 11/2016 - 05/2015
7	SofosbuvirIBA 01/2018 - 05/2015
4	sofosbuvir drug combination ledipasvirIBA 11/2016 - 06/2015
3	Antiviral Agents (Antivirals)IBA 04/2024 - 04/2016
3	ledipasvirIBA 01/2018 - 06/2015
3	Interferon-alpha (Interferon Alfa)IBA 11/2016 - 01/2016
3	InterferonsIBA 07/2016 - 06/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2022
2	TabletsIBA 11/2016 - 07/2016
2	NucleotidesIBA 01/2016 - 06/2015
1	Hepatitis B e AntigensIBA 11/2022
1	entecavir FDA Link 11/2022
1	Reverse Transcriptase InhibitorsIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 06/2015
1	CreatinineIBA 06/2015
1	triphenyltetrazoliumIBA 01/2015
1	salicylhydroxamic acid (SHAM)IBA 01/2012

Therapy/Procedure

5	Therapeutics 04/2024 - 01/2012
2	Aftercare (After-Treatment) 04/2024 - 07/2016
1	Duration of Therapy 04/2024
1	Surgical Instruments (Clip) 01/2012